Xcout Intel
Debiopharm
Debiopharm is an independent biopharmaceutical company based in Switzerland that develops treatments for oncology and infectious diseases. The company focuses on drug development, drug manufacturing, and strategic investments in digital health and smart data start-ups.
Subscribe to see Debiopharm’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Debiopharm at a glance
Debiopharm is a biotech company headquartered in Switzerland. Xcout tracks 7 named people at Debiopharm, including Bertrand Ducrey (Chief Executive Officer, Debiopharm International & Senior Vice-Chairman, Debiopharm). Xcout recorded 8 job postings from Debiopharm in the last 90 days.
Debiopharm leadership
- Bertrand DucreyChief Executive Officer, Debiopharm International & Senior Vice-Chairman, Debiopharm
- Angela ZubelChief Development Officer, Research & Development
- Frederic LevyChief Scientific Officer, Search & Evaluation and Scientific Innovation
- Nicolas FavreChief Business Officer, Business Development & Commercial
- Pierre JullianChief Finance Officer, Finance, HR, IT & Administration
- Vanessa CurratChief Legal Officer, Legal Affairs, Intellectual Property & Pre-Commercial Alliances
1 more named person on record for Debiopharm, with roles, board committees and tenure — see the full roster →
Hiring at Debiopharm
Xcout recorded 8 job postings from Debiopharm in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Debiopharm's hiring signals →
Debiopharm competitors
A few of Debiopharm's closest competitors — see the full list of competitors and alternatives →
D3 Bio is a biopharmaceutical company headquartered in Shanghai, China, focused on the discovery and development of innovative oncology and immunology medicines.
Oncomatryx is a Spanish biopharmaceutical company headquartered in Derio, Basque Country, Spain. The firm pioneers targeted oncology therapeutics aimed at treating metastatic solid tumors and utilizes advanced computational approaches in its drug discovery pipeline.
Oncodesign Precision Medicine is a biopharmaceutical company that develops innovative therapeutic and diagnostic solutions targeting treatment resistance, metastasis, and diseases such as oncology, inflammatory bowel disease, and Parkinson's disease. Utilizing proprietary technologies like OncoSNIPER, Nanocyclix, and PROMETHE, the company advances first-in-class and best-in-class precision medicine programs to serve patients, clinicians, and pharmaceutical partners.
Celyad Oncology is a biopharmaceutical company headquartered in Mont-Saint-Guibert, Belgium, focused on the development of innovative therapies.
BioVersys AG is an award-winning, privately-owned Swiss pharmaceutical and biotech company headquartered in Basel, Switzerland, focused on the research and development of antibacterial treatments for drug-resistant bacterial infections.
Philogen is a Swiss-Italian biotechnology company that focuses on the research, development, and commercialization of targeted therapeutics for the treatment of cancer and other serious conditions. The company utilizes proprietary antibody-based technologies to develop biopharmaceuticals, immunotherapies, and radio-conjugates for oncology and imaging applications.
Get Debiopharm's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Debiopharm in Xcout Intel
- 7 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access